Nicholas Brandon
Chief Scientific OfficerDr. Nicholas Brandon, also known as Nick, Ph.D., serves as Chief Scientific Officer at Neumora Therapeutics, Inc since January 2022. Dr. Brandon is an Adjunct Professor at Tufts Medical School and is an honorary professor at the University of Glasgow. Prior to Neumora, he served as Senior Vice President and Head of Biology at Jnana Therapeutics, where he built a research organization focussed on rare neurological indications and immunometabolism. He was at AstraZeneca, where he held the positions of chief scientist and head of neuroscience discovery. At AstraZeneca, he led multiple programs that delivered clinical assets or re-positioned assets for new indications and led a number of significant partnerships, including with Tufts University, where he founded the AstraZeneca-Tufts lab for Basic and Translational Neuroscience and the Lieber Institute for Brain Development. He also created and oversaw the AstraZeneca biotech incubator space in Boston and was an AstraZeneca-Flagship Pioneering research fellow. He was head of psychiatry and behavioral disorders for a period that bridged the Wyeth and Pfizer Neuroscience organizations, where his drug discovery interests were focused on schizophrenia, bipolar disorder and treatment resistant depression. He began his career in industry with Merck at the Terlings Park site in the UK. He is a fellow of the American College of Neuropsychophamacology (ACNP) and has published over 150 peer-reviewed publications. He holds an undergraduate degree in genetics from Pembroke College, Cambridge and a Ph.D. from University College London.
Positions
- Company NameNeumora Therapeutics, Inc.Stock CodeNMRAPositionChief Scientific OfficerColleagues
